Denotivir is an antiviral agent belonging to the isothiazole derivative class, primarily developed to combat human herpes simplex virus types 1 and 2, as well as the varicella zoster virus. By inhibiting… Read more
Denotivir is an antiviral agent belonging to the isothiazole derivative class, primarily developed to combat human herpes simplex virus types 1 and 2, as well as the varicella zoster virus. By inhibiting viral DNA polymerase, this compound effectively prevents viral replication within host cells. This category features high-quality reference standards of the Denotivir active pharmaceutical ingredient (API), essential for analytical testing and precise method validation. Pharmaceutical laboratories utilize these materials, including pharmacopeial and non-pharmacopeial impurities, to perform rigorous impurity profiling during drug development and stability studies. Furthermore, stable isotope-labelled compounds are available to serve as reliable internal standards for mass spectrometry-based assays. Researchers rely on these comprehensive reference materials to ensure the accuracy of quality control protocols and to meet regulatory compliance standards when evaluating the purity and consistency of Denotivir formulations.